ADMINISTRATIVE BUDGET

行政预算

基本信息

  • 批准号:
    7959666
  • 负责人:
  • 金额:
    $ 28.94万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-07-01 至 2010-06-30
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The Principal Investigator of the Program, Dr. Jos¿ R. Carlo-Izquierdo, Chancellor of the Medical Sciences Campus, has the responsibility of ensuring that program goals are met and that appropriate institutional support is provided to the program. All responsibilities of daily operations are delegated to the Program Director. The RCRII Program has a Director, an Associate Director, and an Assistant Director. The combined percentage of their effort provides 100% of a full time position. The Program Director, Dr. Julio E. Benabe, has a 40% time effort and oversees the entire program. He presides a weekly staff meeting where all issues concerning the daily activities of the RCRII are reviewed and discussed with the entire staff. The PD also attends the monthly meeting with the RCAC and reports to them the important issues related to new studies, development of established collaborations, and the links with the participating programs supported by the RCRII. As the Associate Chief of Staff for R&D at the VA Hospital, it is not possible for Dr. Benabe to be physically present in the unit at all times, however, the Associate Director, Dr. Carlos Luciano (35%), and the Assistant Director, Dr. Marcia Cruz (25%), allow for a constant presence of one of the Directors and assist the P.D. in all aspects of the operation of the program. The Associate Program Director serves as a liaison with the faculty and administrative mechanisms in the Medical Sciences Campus, facilitating the implementation of the program's goals and specific aims within the institution. The Research Clinical Advisory Committee (RCAC) has an instrumental role in the directorship of the RCRII. The RCAC is composed of two subcommittees, an internal subcommittee composed of faculty and investigators from the UPR-MSC and an External Subcommittee composed of our external advisors Drs. Brater, Watkins, and Palefsky. The RCAC is responsible for approving all the protocols conducted at the RCRII, for the process of selection of the pilot projects, for the allocation of RCRII resources, and for overseeing the operation and the policies of the RCRII. It also provides advice to the P.I. and the PDs on scientific initiatives. The Internal Subcommittee of the RCAC meets on a monthly basis to review submitted protocols and the general direction of the RCRII. The committee evaluates each protocol using a standard format developed and approved by the committee to address all the relevant issues pertaining protocols at the RCRII. Each protocol is reviewed by two "primary" reviewers who are voting members of the committee and then are considered by the committee as a whole. Additional input from the biostatistician and the RSA is requested. The PD, Associate PD, and Assistant PD attend each of the RCAC monthly meetings as non-voting members. They discuss all matters pertaining to the daily activities at the RCRII, compliance with all the regulations to conduct clinical research in a federally funded program, review data and safety monitoring plans for all new protocols, and participate in the discussion and assessment of all new protocols applying for use of the RCRII facilities as well as in the proposed collaborations with other programs.
该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金, 因此可以出现在其他 CRISP 条目中 列出的机构是。 对于中心来说,它不一定是研究者的机构。 该项目的首席研究员 Jos¿医学科学校区校长 R. Carlo-Izquierdo 负责确保实现项目目标,并为项目提供适当的机构支持。日常运营的所有职责均委托给项目主任。 RCRII 项目有一名主任、一名副主任和一名助理主任,他们的工作量合计占全职职位的 100%。项目主任 Julio E. Benabe 博士投入了 40% 的时间并负责监督。他主持每周一次的员工会议,与全体员工一起审查和讨论与 RCRII 日常活动相关的所有问题。PD 还参加与 RCAC 举行的每月会议,并向他们报告与新项目相关的重要问题。作为 VA 医院负责研发的副参谋长,Dr. Benabe 始终亲自在该单位,但是,副主任 Carlos Luciano 博士 (35%) 和助理主任 Marcia Cruz 博士 (25%) 允许其中一名人员持续存在项目副主任负责项目运作的各个方面,并协助项目博士负责与医学科学校区的教师和行政机制的联络,促进项目目标和机构内具体目标的实施。 研究临床咨询委员会 (RCAC) 在 RCRII 的领导中发挥着重要作用。RCAC 由两个小组委员会组成,一个是由 UPR-MSC 的教员和研究人员组成的内部小组委员会,另一个是由我们的外部顾问博士组成的外部小组委员会。 Brater、Watkins 和 Palefsky 负责批准 RCRII 的所有试验项目选择过程。 RCRII资源的分配,以及监督运作和 它还向 P.I 和 PD 提供有关科学举措的建议。 RCAC 的内部小组委员会每月举行一次会议,审查提交的方案和 RCRII 的总体方向。该委员会使用委员会制定和批准的标准格式评估每个方案,以解决与 RCRII 方案有关的所有相关问题。每个方案均由作为委员会投票成员的两名“主要”审查员进行审查,然后由生物统计学家和 RSA 助理进行整体考虑。 PD 和助理 PD 作为无投票权成员参加每次 RCAC 月度会议,他们讨论与 RCRII 日常活动、遵守在联邦资助项目中进行临床研究的所有法规、审查数据和安全相关的所有事项。监督所有新协议的计划,并参与申请使用 RCRII 设施的所有新协议的讨论和评估以及与其他项目的拟议合作。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jose R. Carlo其他文献

Jose R. Carlo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jose R. Carlo', 18)}}的其他基金

RCMI Multidisciplinary Collaborative Research Program
RCMI 多学科合作研究计划
  • 批准号:
    7920757
  • 财政年份:
    2009
  • 资助金额:
    $ 28.94万
  • 项目类别:
EFFECT SIZE FROM PTSD EXPOSURE THERAPY TRAIL
创伤后应激障碍 (PTSD) 暴​​露治疗轨迹的影响大小
  • 批准号:
    7959669
  • 财政年份:
    2009
  • 资助金额:
    $ 28.94万
  • 项目类别:
NEUROPROTECTIVES FOR HIV-ASSOCIATED NEUROCOGNITIVE DISORDERS
针对 HIV 相关神经认知障碍的神经保护剂
  • 批准号:
    7959668
  • 财政年份:
    2009
  • 资助金额:
    $ 28.94万
  • 项目类别:
SPATIAL LEARNING - PILOT STUDY
空间学习 - 试点研究
  • 批准号:
    7959670
  • 财政年份:
    2009
  • 资助金额:
    $ 28.94万
  • 项目类别:
GENETIC EPIDEMIOLOGY AND MOLECULAR PATHOLOGY OF COLORECTAL CANCER IN HISPANICS
西班牙裔结直肠癌的遗传流行病学和分子病理学
  • 批准号:
    7959667
  • 财政年份:
    2009
  • 资助金额:
    $ 28.94万
  • 项目类别:
RCMI MULTIDISCIPLINARY COLLABORATIVE RESEARCH PROGRAM - ADMINISTRATIVE COMPONENT
RCMI 多学科合作研究计划 - 管理部分
  • 批准号:
    7959192
  • 财政年份:
    2009
  • 资助金额:
    $ 28.94万
  • 项目类别:
RCMI Multidisciplinary Collaborative Research Program
RCMI 多学科合作研究计划
  • 批准号:
    7933229
  • 财政年份:
    2009
  • 资助金额:
    $ 28.94万
  • 项目类别:
RCMI MULTIDISCIPLINARY COLLABORATIVE RESEARCH PROGRAM - ADMINISTRATIVE COMPONENT
RCMI 多学科合作研究计划 - 管理部分
  • 批准号:
    7715295
  • 财政年份:
    2008
  • 资助金额:
    $ 28.94万
  • 项目类别:
ADMINISTRATIVE BUDGET: AIDS
行政预算:艾滋病
  • 批准号:
    7720571
  • 财政年份:
    2008
  • 资助金额:
    $ 28.94万
  • 项目类别:
GENES REGULATED BY TWIST2
受 TIST2 调控的基因
  • 批准号:
    7720573
  • 财政年份:
    2008
  • 资助金额:
    $ 28.94万
  • 项目类别:

相似海外基金

NeuroMAP Phase II - Administrative Core
NeuroMAP 第二阶段 - 管理核心
  • 批准号:
    10711135
  • 财政年份:
    2023
  • 资助金额:
    $ 28.94万
  • 项目类别:
Administrative Core A
行政核心A
  • 批准号:
    10891051
  • 财政年份:
    2023
  • 资助金额:
    $ 28.94万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10628879
  • 财政年份:
    2023
  • 资助金额:
    $ 28.94万
  • 项目类别:
The Center for Innovation and Translation of Point of Care Technologies for Equitable Cancer Care (CITEC) - Administrative Core
公平癌症护理护理点技术创新与转化中心 (CITEC) - 行政核心
  • 批准号:
    10715741
  • 财政年份:
    2023
  • 资助金额:
    $ 28.94万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10749843
  • 财政年份:
    2023
  • 资助金额:
    $ 28.94万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了